Gastroenterology News and Research

RSS

Gastroenterology is the branch of medicine where the digestive system and its disorders are studied.

Study identifies trends in the use of glucagon-like peptide-1 receptor agonists

Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)-;prescription medications sold under popular drug names like Ozempic and Wegovy-;in the United States.

22 Jul 2024

AGA releases new clinical guidance to help recognize the symptoms of cyclic vomiting syndrome

The American Gastroenterological Association (AGA) has released new clinical guidance to help clinicians and patients recognize the signs and symptoms of cyclic vomiting syndrome (CVS).

16 Jul 2024

NYU Langone Health earns No. 1 spot in neurology and neurosurgery for the third straight year

NYU Langone Health has reaffirmed its position as the nation's top hospital for neurology and neurosurgery, securing the No. 1 ranking for the third straight year in U.S. News & World Report's annual assessment of leading hospitals.

16 Jul 2024

Mainz Biomed seeks FDA’s Breakthrough Devices Designation for advanced colorectal cancer test

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced that it has submitted its application to the U.S. Food and Drug Administration (FDA) requesting Breakthrough Device Designation for its non-invasive Next Generation colorectal cancer (CRC) product including the Company’s novel portfolio of mRNA biomarkers. Subject to the FDA’s review, a Breakthrough Device Designation could significantly accelerate approval.

13 Jul 2024

Researchers uncover the incidence and prevalence of eosinophilic esophagitis in Japan

In one of the first studies of its kind in Japan, Osaka Metropolitan University-led researchers uncovered the incidence and prevalence of the chronic allergic disorder eosinophilic esophagitis, or EoE.

10 Jul 2024

Gut Blastocystis linked to good cardiovascular health and lower body fat

In an analysis of more than 50,000 individuals from around the world, carriers of gut Blastocystis, a single-celled organism that has been labeled either a parasite or harmless organism but is commonly found in the digestive system, was linked to indicators of good cardiovascular health and decreased body fat.

8 Jul 2024

Enhancing viral therapy for resistant cancers with a metabolite-drug

When a cancer cell doesn't respond to traditional therapies, doctors may turn to a sort of viral biological warfare, by deploying 'troops' in the form of viral agents that are specifically engineered to target and eliminate cancer cells.

28 Jun 2024

New research may help explain recurrent Crohn's disease in children

Remarkable new research by a University of Virginia undergraduate may help explain recurrent Crohn's disease in children and open the door to new ways to treat or even cure the devastating condition.

28 Jun 2024

New study casts doubt on lipid-lowering strategies for IBD prevention

A new study has illuminated the connection between inflammatory bowel disease (IBD) and lipid profile. IBD is a chronic condition that causes inflammation in the intestines. Abnormal lipid factor levels such as cholesterol in IBD patients have been observed in previous studies, but whether this association is causal remained unclear.

28 Jun 2024

PFDN6 protein could be a new target for colorectal cancer treatment

Researchers have identified a protein called PFDN6 that may play a role in the development and spread of colorectal cancer (CRC).

27 Jun 2024

Using AI to improve gastroscopy diagnostics

During a gastroscopy, the oesophagus, stomach and duodenum are examined using an endoscope. This is a thin, flexible tube with a light and a camera at the tip.

24 Jun 2024

Challenges in treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis

Primary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type called cholangiocarcinoma (CCA).

20 Jun 2024

NTU Singapore study reveals high trust in AI among gastroenterologists

Artificial intelligence (AI) has permeated many aspects of medicine, with promises of accurate diagnoses, better management decisions, and improved outcomes for both patients and the healthcare system.

18 Jun 2024

Empowering communities: Penn Medicine's annual mammogram event and health fair

Penn Medicine will once again join with community partners and Siemens Healthineers to host a free mammogram clinic and community health fair in June, giving the West Philadelphia and Upper Darby communities convenient access to health screenings right in their neighborhoods.

13 Jun 2024

New research sheds light on IL-23's role in chronic inflammatory bowel diseases

Scientists at Weill Cornell Medicine discovered a previously unknown link between two key pathways that regulate the immune system in mammals-;a finding that impacts our understanding of chronic inflammatory bowel diseases (IBD).

12 Jun 2024

Understanding Crohn's disease through 'mini-gut' models

Cambridge scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an important role in the disease and how it presents in patients.

10 Jun 2024

New soft-robotic device restores natural esophageal motion for improved digestion

A team of Vanderbilt researchers has developed a wirelessly activated device that mimics the wavelike muscular function in the esophagus and small intestine responsible for transporting food and viscous fluids for digestion.

7 Jun 2024

Bile acids: Balancing digestive health and liver toxicity

Bile acids are essential molecules the liver produces that play a critical role in digestion. They help us absorb fat-soluble vitamins and cholesterol from our food.

6 Jun 2024

Key studies on GLP-1 drugs, alpha-gal syndrome, and liver disease medications to be presented at DDW 2024

Studies examining the risks of GLP-1 weight-loss drugs, distinguishing alpha-gal syndrome from other GI disorders, and comparing medications to slow the progression of liver disease in patients with alcohol-use disorder will be presented this week at Digestive Disease Week (DDW) 2024.

21 May 2024

Latest advances in gastric cancer and other cancer-related studies to be presented at DDW 2024

Cancer-related studies, including a diagnostic tool for gastric cancer and trends in gallbladder and colorectal cancers, will be presented this week at Digestive Disease Week (DDW) 2024.

21 May 2024

Gastroenterology News and Research

Further Reading

Study identifies trends in the use of glucagon-like peptide-1 receptor agonists

AGA releases new clinical guidance to help recognize the symptoms of cyclic vomiting syndrome

NYU Langone Health earns No. 1 spot in neurology and neurosurgery for the third straight year

Mainz Biomed seeks FDA’s Breakthrough Devices Designation for advanced colorectal cancer test

Researchers uncover the incidence and prevalence of eosinophilic esophagitis in Japan

Gut Blastocystis linked to good cardiovascular health and lower body fat

Enhancing viral therapy for resistant cancers with a metabolite-drug

New research may help explain recurrent Crohn's disease in children

New study casts doubt on lipid-lowering strategies for IBD prevention

PFDN6 protein could be a new target for colorectal cancer treatment

Using AI to improve gastroscopy diagnostics

Challenges in treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis

NTU Singapore study reveals high trust in AI among gastroenterologists

Empowering communities: Penn Medicine's annual mammogram event and health fair

New research sheds light on IL-23's role in chronic inflammatory bowel diseases

Understanding Crohn's disease through 'mini-gut' models

New soft-robotic device restores natural esophageal motion for improved digestion

Bile acids: Balancing digestive health and liver toxicity

Key studies on GLP-1 drugs, alpha-gal syndrome, and liver disease medications to be presented at DDW 2024

Latest advances in gastric cancer and other cancer-related studies to be presented at DDW 2024

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest News